Shortages of Prescription Drugs Due to Compliance and Quality Issues in Japan-Reference-Cited by-同舟云学术

Shortages of Prescription Drugs Due to Compliance and Quality Issues in Japan

Published:2023-02-01 Issue:2 Volume:143 Page:139-152
ISSN:0031-6903
Container-title:YAKUGAKU ZASSHI
language:en
Short-container-title:YAKUGAKU ZASSHI

Author:

Izutsu Ken-ichi¹,Abe Yasuhiro¹,Kurita Mari¹,Yoshida Hiroyuki¹

Affiliation:

1. Division of Drugs, National Institute of Health Sciences

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/yakushi/143/2/143_22-00185/_pdf

Reference78 articles.

1. 1) Tobita Y., Yamamoto G., Kudou T., Yumoto T., Hoken Iryou Kagaku, 71, 140–146 (2022).

2. 2) McBride A., Holle L. M., Westendorf C., Sidebottom M., Griffith N., Muller R. J., Hoffman J. M., Am. J. Health Syst. Pharm., 70, 609–617 (2013).

3. 3) Gray A., Manasse H. R. J. Jr., Bull. World Health Organ., 90, 158–158A (2012).

4. 4) Ministry of Health, Labour and Welfare. “Good manufacturing control and quality control of generic drugs.”: 〈https://www.mhlw.go.jp/content/10601000/000869784.pdf〉, cited 9 October, 2022.

5. 5) The federation of Pharmaceutical Manufactures’ Association of Japan. “Recent efforts to secure a stable supply of pharmaceuticals.”: 〈https://www.mhlw.go.jp/content/10807000/000918556.pdf〉, cited 9 October, 2022.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of non-compliances identified in GMP inspections between 2013 and 2022;Pharmacia;2024-03-08

2. 販売中止となった後発医薬品の特徴に関する調査;YAKUGAKU ZASSHI;2023-12-01

3. Generic Drug Shortage in Japan: GMP Noncompliance and Associated Quality Issues;Journal of Pharmaceutical Sciences;2023-07

4. Drug Shortages in South-Western China: A Regional Multi-Source Reporting Data Analysis;2023